Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABAX --- lots of upside -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (363)	11/13/1997 4:27:00 PM
From: Yo Yo	Read Replies (1) \| Respond to of 492

Take over, hummmm???? At what price? I have not heard much lately on the Japanese joint development project. Your right, if they get new tests approved, it will be time to buy. And according to you, thats a year away. And we all know how development schedules tend to slip. I imagine if I owned the stock now, I would hold. But on that schedule, I'll BEGIN looking in a few months). On the take over front, I don't see Abaxis in the strongest of positions. They are losing money and will need more funding in about a year, especially if they start to hit the human market hard. There is competition coming to the automated test market in the next year also. Do you see something else that makes them a takeover candidate any time soon? Otherwise, if I were a buyer, I would let them sweat a while until they perfect things and get them at a lower price. I do LOVE the concept, I am just thinking that I might get the stock cheaper in a few months. Yo Yo